Send to

Choose Destination
See comment in PubMed Commons below
Neuron. 2003 Jun 5;38(5):685-8.

Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis.

Author information

Department of Neurology, University of California, San Francisco, San Francisco, CA 94143, USA.


Multiple sclerosis (MS) is an autoimmune central nervous system (CNS) demyelinating disease that causes relapsing and chronic neurologic impairment. Recent observations have altered certain traditional concepts regarding MS pathogenesis. A greater diversity of cell types and molecules involved in MS is now evident. While remyelination can occur during the early inflammatory phase when damage may be reversible, it is impaired in the later stages, which involve axonal death. These observations have important therapeutic implications.

[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center